Search On This Site

Custom Search


It only takes a few moments to share an article, but the person on the other end who reads it might have his life changed forever
Subscribe via RSS



Contact Information: 
Submit: articles [ at ] investmentwatchblog [dot] com 
Advertising: ads [ at ] investmentwatchblog [dot] com 
General: admin [ at ] investmentwatchblog [dot] com

WHO Calls ‘Emergency Meeting’, Setting the Stage to Ok ‘Experimental’ Ebola Drugs!


NEW YORK – The World Health Organization will host a closed-door conference in Geneva with some 100 health-care experts from around the world to explore the alternative medical treatments and experimental drugs available to combat Ebola.

The WHO hopes the conference, Sept. 4-5, will lead to the approval of one or more treatments to combat the current Ebola outbreak in Africa.

WHO spokeswoman Fadela Chaib in Geneva explained to WND in an exclusive telephone interview that while journalists will be excluded from the meeting, the WHO will conduct a media advisory at the conclusion to allow journalists to ask questions.

The WHO decision to explore experimental Ebola drugs and treatments appears to have been prompted in part by a widely reported offer made Monday by the Japanese company Toyama Chemical, a pharmaceutical subsidiary of the photo giant Fujifilm.

The Japanese company will deliver to the WHO at no cost a quantity of the experimental drug Favipiravir, originally known as “T-705.” The drug is marketed by Toyama Chemical under the trade name “Avigan.” The company will supply enough doses for 20,000 people in an attempt to control the Ebola outbreak affecting West Africa.

Yoshihide Suga, a spokesman for the Japanese cabinet, affirmed Toyama Chemical is ready to ship the drug at any time to West Africa upon the approval of the WHO. He said Japan’s health ministry approved in March the use of Avigan against influenza.

Fujifilm is in talks with the U.S. Food and Drug Administration through a U.S. partner, Boston-based MediVector, to prepare for clinical testing of the drug in the United States, the Associated Press reported Monday.

Read more at http://www.wnd.com/2014/08/who-calls-…

225 Total Views 1 Views Today
Did you already share this? No? Share it now:
  • Lynn Peters

    I suggest all Bush and Obama supporters line up to be guinea pigs, I mean research study participants.

  • hvaiallverden

    Then My next question is, is this epidemic(pandemic) a biological wepond since they ars afraid of publisity, its becoming obvious, and the second is that do They or are They letting the epidmic slide out of controll, to boulster the medical ind. complex so it can have ever more fraudelent vacsins to pimp on the public, by hammering doomsdays senarios.

    What baffles me is the somehow weird lack of taking this as seriously as it sould be dealth with, because Ebola is the uglyest and fastet epidemic there is, and spreads f…. easely, and even the morons in Charge dont seem to realise that, it is no f….. joke, ebola.
    And so far they have behaved equally inefficient as the Fukushima radiation case, it looks like we have given our helth care to an bunch of corrupted and downright stupid people.

    This isnt something to take lightly, ebola is a f….. problem and can escalate in unpressedented scale, in an hartbeat.
    And the vacise is and I belive to be a total hoax.
    So far, non have any effect, and I wounder what do they putt in it, since the vacsine have to have a initiater that mimics the plage its supousedly made to hinder, like the scam about last bigg epidemic.

    peace